000 | 01056 a2200289 4500 | ||
---|---|---|---|
005 | 20250517195557.0 | ||
264 | 0 | _c20191003 | |
008 | 201910s 0 0 eng d | ||
022 | _a1758-1095 | ||
024 | 7 |
_a10.1177/0141076817750554 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMarquardsen, Mikkel | |
245 | 0 | 0 |
_aRedactions in protocols for drug trials: what industry sponsors concealed. _h[electronic resource] |
260 |
_bJournal of the Royal Society of Medicine _cApr 2018 |
||
300 |
_a136-141 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aDenmark |
650 | 0 | 4 | _aDrug Industry |
650 | 0 | 4 |
_aEthics Committees, Research _xorganization & administration |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aOgden, Michelle | |
700 | 1 | _aGøtzsche, Peter C | |
773 | 0 |
_tJournal of the Royal Society of Medicine _gvol. 111 _gno. 4 _gp. 136-141 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0141076817750554 _zAvailable from publisher's website |
999 |
_c28014731 _d28014731 |